---
title: "Veerhealth Care Ltd (511523) — Share Price, Financials & Analysis"
symbol: "511523"
company: "Veerhealth Care Ltd"
canonical: "https://tapetide.com/stocks/511523"
isin: "INE882C01035"
nse_symbol: "VEERHEALTHCARELTD"
bse_code: "511523"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 102.22
generated_at: "2026-09-13T18:37:05.992Z"
---

# Veerhealth Care Ltd (511523)

Canonical page: https://tapetide.com/stocks/511523

## Company

- **NSE Symbol:** VEERHEALTHCARELTD
- **BSE Code:** 511523
- **ISIN:** INE882C01035
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** veerhealthcare.net

## About

Incorporated in 1992, Veer Healthcare Ltd is in the business of trading, manufacturing and marketing research based ayurvedic medicines[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:48:39.515582Z.

- **Market Cap:** ₹102.22 Cr
- **Classification:** Microcap
- **P/E (reported):** 64.9
- **EPS (TTM):** ₹0.77
- **EPS (reported):** ₹0.2
- **Book Value:** ₹11.46
- **Price to Book:** 4.36
- **Dividend Yield:** 0%
- **ROE:** 1.76%
- **ROCE:** 2.55%
- **Debt to Equity:** 0.2
- **Revenue (yearly):** ₹32.48 Cr
- **Net Income:** ₹1.04 Cr
- **EBITDA:** ₹2.15 Cr
- **52-Week High:** ₹51.84
- **52-Week Low:** ₹16.7
- **RSI (14):** 73.16

## Tapetide Score

- **Score:** 57 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 77.8 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 50.49 | 9% |
| growth | 98.9 | 9% |
| momentum | 98.9 | 12% |
| ownership | 52.32 | 24% |
| quality | 53.25 | 22% |
| valuation | 32.33 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter
- Company's working capital requirements have reduced from 158 days to 51.4 days

### Weaknesses

- Stock is trading at 4.42 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 31.9%
- Company has a low return on equity of 2.22% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -113.45% | 44.29% | -139% |
| ebitda margin growth | 250% | -31.2% | -52.81% | -13.87% |
| net income growth | 500% | 160% | -25% | 12% |
| revenue growth | 47.65% | 81.45% | 35% | 25% |
| roce | — | -49.9% | -44.69% | 3.74% |
| roe | — | -5.38% | 3.67% | -34.81% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3.83 | 2.87 | 3.37 | 2.06 | 5.15 | 3.84 | 5.62 | 4.49 | 3.98 | 7.26 | 16.76 | 24.93 |
| Expenses | 3.62 | 2.7 | 3.2 | 2.08 | 4.67 | 3.69 | 5.78 | 4.52 | 3.45 | 6.02 | 16.03 | 23.02 |
| Operating Profit | 0.21 | 0.17 | 0.17 | -0.02 | 0.48 | 0.15 | -0.16 | -0.03 | 0.53 | 1.24 | 0.73 | 1.91 |
| OPM % | 5.48 | 5.92 | 5.04 | -0.97 | 9.32 | 3.91 | -2.85 | -0.67 | 13.32 | 17.08 | 4.36 | 7.66 |
| Other Income | 0.42 | 0.24 | 0.17 | 0.36 | 0.25 | 0.18 | 0.43 | 0.65 | 0.23 | -0.29 | -0.09 | 0.16 |
| Interest | 0 | 0 | 0 | 0 | 0.11 | 0.01 | 0.14 | 0.1 | 0.1 | 0.1 | 0.11 | 0.23 |
| Depreciation | 0.18 | 0.18 | 0.18 | 0.19 | 0.2 | 0.25 | 0.26 | 0.28 | 0.31 | 0.35 | 0.35 | 0.36 |
| Profit before tax | 0.45 | 0.23 | 0.16 | 0.15 | 0.42 | 0.07 | -0.13 | 0.24 | 0.35 | 0.5 | 0.18 | 1.48 |
| Tax % | 13.33 | 17.39 | 443.75 | 20 | 28.57 | 0 | -23.08 | 0 | 25.71 | 18 | 294.44 | 16.89 |
| Net Profit | 0.39 | 0.19 | -0.55 | 0.12 | 0.3 | 0.07 | -0.1 | 0.24 | 0.25 | 0.4 | -0.35 | 1.23 |
| EPS in Rs | 0.2 | 0.1 | -0.28 | 0.06 | 0.15 | 0.04 | -0.05 | 0.12 | 0.13 | 0.2 | -0.18 | 0.62 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 5.17 | 5.98 | 11.72 | 10.62 | 9.64 | 13.28 | 13.22 | 16.67 | 32.48 | 52.93 |
| Expenses | 5.29 | 5.54 | 11.04 | 10.56 | 10.46 | 12.78 | 12.61 | 16.21 | 30.02 | 48.52 |
| Operating Profit | -0.12 | 0.44 | 0.68 | 0.06 | -0.82 | 0.5 | 0.61 | 0.46 | 2.46 | 4.41 |
| OPM % | -2.32 | 7.36 | 5.8 | 0.56 | -8.51 | 3.77 | 4.61 | 2.76 | 7.57 | 8.33 |
| Other Income | 0.72 | 0.29 | 0.48 | 1.2 | 1.67 | 1.24 | 1.39 | 1.22 | 0.49 | 0.01 |
| Interest | 0.07 | 0.03 | 0.19 | 0.22 | 0.09 | 0 | 0.01 | 0.26 | 0.4 | 0.54 |
| Depreciation | 0.27 | 0.32 | 0.32 | 0.47 | 0.52 | 0.62 | 0.71 | 0.91 | 1.29 | 1.37 |
| Profit before tax | 0.26 | 0.38 | 0.65 | 0.57 | 0.24 | 1.12 | 1.28 | 0.51 | 1.26 | 2.51 |
| Tax % | 42.31 | 57.89 | 50.77 | 35.09 | 129.17 | -41.07 | 68.75 | 23.53 | 56.35 | — |
| Net Profit | 0.14 | 0.16 | 0.32 | 0.38 | -0.07 | 1.58 | 0.41 | 0.39 | 0.54 | 1.53 |
| EPS in Rs | 0.1 | 0.12 | 0.23 | 0.27 | -0.05 | 0.79 | 0.21 | 0.2 | 0.27 | 0.77 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 10 | 20 | 20 | 20 |
| Reserves | 5.92 | 6.17 | 6.35 | 6.82 | 7.11 | 7.02 | 11.43 | 1.84 | 2.22 | 2.92 |
| Borrowings | -0.17 | 1.21 | 0.94 | 2.48 | 1.73 | 0 | 0 | 0 | 4.91 | 4.58 |
| Other Liabilities | 0.37 | 0.42 | 1.94 | 1.76 | 2.96 | 6.2 | 3.82 | 6.28 | 6.65 | 16.67 |
| Total Liabilities | 13.05 | 14.73 | 16.16 | 17.99 | 18.73 | 20.15 | 25.25 | 28.12 | 33.78 | 44.17 |
| Fixed Assets | 2.52 | 5.54 | 5.46 | 9.45 | 9.48 | 10.54 | 12.01 | 11.97 | 19.87 | 23.43 |
| CWIP | 0 | 0.24 | 2.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 10.53 | 8.95 | 8.51 | 8.54 | 9.25 | 9.61 | 13.24 | 16.15 | 13.91 | 20.74 |
| Total Assets | 13.05 | 14.73 | 16.16 | 17.99 | 18.73 | 20.15 | 25.25 | 28.12 | 33.78 | 44.17 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1.69 | 1.76 | 1.98 | -0.36 | 1 | 1.81 | -0.7 | 2.9 | -0.39 | 4.19 |
| Cash from Investing Activity | -0.44 | -3.02 | -1.9 | -1.67 | -0.09 | -1.09 | -1.79 | -0.28 | -8.2 | -4.43 |
| Cash from Financing Activity | -1.33 | 1.31 | 0.02 | 1.85 | -0.83 | -0.42 | 5.69 | -5.99 | 9.52 | -0.46 |
| Net Cash Flow | -0.08 | 0.06 | 0.1 | -0.17 | 0.09 | 0.3 | 3.21 | -3.37 | 0.92 | -0.7 |
| Free Cash Flow | 1.66 | -1.78 | -0.21 | -2.48 | 0.5 | 0.23 | -2.79 | 2.22 | -9.2 | -0.67 |
| CFO/OP | -253 | -1550 | 480 | -44 | 2050 | -226 | -100 | 523 | -65 | 179 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 117.8 | 64.95 | 45.17 | 29.27 | 52.93 | 58.31 | 50.57 | 108.23 | 70.28 | 109.46 |
| Inventory Days | 477.31 | 93.49 | 77.82 | 54.35 | 76.21 | 102.76 | 103.21 | 55.97 | 78.12 | 67.26 |
| Days Payable | 68.63 | 18.9 | 145.44 | 37.12 | 42.24 | 112.46 | 21.75 | 86.35 | 83.89 | 183.18 |
| Cash Conversion Cycle | 526.48 | 139.54 | -22.46 | 46.51 | 86.9 | 48.61 | 132.03 | 77.85 | 64.52 | -6.47 |
| Working Capital Days | 1597.12 | 393.95 | 8.55 | 145.44 | 177.34 | 127.6 | 158.31 | 288.52 | 134.88 | 51.36 |
| ROCE % | 0.98 | 2.45 | 2.87 | 5.52 | 4.94 | 2.22 | 6.33 | 5.96 | 3.14 | 7.21 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 30.76% | 30.76% | 30.41% | 30.41% | 30.41% | 30.41% | 31.5% | 31.5% | 31.5% | 31.5% | 31.5% | 31.91% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 56.23% | 56.8% | 60.05% | 59.25% | 58.57% | 58.53% | 58.35% | 57.92% | 56.97% | 55.12% | 54.27% | 53.97% |
| Others | 13.01% | 12.44% | 9.54% | 10.33% | 11.02% | 11.06% | 10.15% | 10.58% | 11.53% | 13.38% | 14.23% | 14.12% |
| No. of Shareholders | 6195 | 6874 | 10991 | 10255 | 11489 | 11469 | 11390 | 11011 | 10846 | 10455 | 10027 | 9315 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 49.85 | Buy |
| EMA (10) | 49.82 | Buy |
| SMA (20) | 49.43 | Buy |
| EMA (20) | 48.85 | Buy |
| SMA (50) | 44.77 | Buy |
| EMA (50) | 44.21 | Buy |
| SMA (100) | 34.78 | Buy |
| EMA (100) | 37.71 | Buy |
| SMA (200) | 26.95 | Buy |
| EMA (200) | 30.72 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 76.4 | Sell |
| MACD (12,26,9) | 1.65 | Sell |
| Stochastic (14,3,3) | 65.5 | Neutral |
| ADX (14) | 32.01 | Buy |
| Williams %R (14) | -23.97 | Neutral |
| ATR (14) | 2.03 | High Volatility |
| ROC (12) | 2.55 | Buy |
| Stoch RSI (14) | 44.17 | Neutral |
| UO (7,14,28) | 60.39 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 6 Feb - Board meeting Feb 14, 2026 to approve unaudited results for nine months ended 31-Dec-2025; trading window reopens Feb 17. | [Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter Ended 31St December, 2025. 6 Feb - Board meeting Feb 14, 2026 to approve unaudited results for nine months ended 31-Dec-2025; trading window reopens Feb 17.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/244b555b-0992-4906-8876-18df8dea266f.pdf) |
| 5 Feb - Board meeting on 13 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025. | [Board Meeting Intimation for Financial Results For Quarter Ended 31St December 2025 5 Feb - Board meeting on 13 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4511ed29-1029-4489-8f76-56388d57f05c.pdf) |
| 30 Apr - Veerhealth Care received repeat order worth ₹1.43 crore from a leading US e-commerce platform. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - Veerhealth Care received repeat order worth ₹1.43 crore from a leading US e-commerce platform.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d52aa6ce-04bf-4e09-a05b-1f2a4b4666c1.pdf) |
| 30 Apr - Veerhealth Care received repeat order worth ₹1.43 crore from a leading US e-commerce platform. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - Veerhealth Care received repeat order worth ₹1.43 crore from a leading US e-commerce platform.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d52aa6ce-04bf-4e09-a05b-1f2a4b4666c1.pdf) |
| 2h - Venugopal Dhoot redesignated Managing Director; resigns as CFO; Deepak Sharma appointed CFO, effective March 6, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 2h - Venugopal Dhoot redesignated Managing Director; resigns as CFO; Deepak Sharma appointed CFO, effective March 6, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/538ccfe6-d8bc-4a75-bc15-c9d716d2bded.pdf) |
| 2h - Venugopal Dhoot redesignated Managing Director; Deepak Sharma appointed CFO; changes effective March 6, 2026; postal ballot for MD. | [Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) 2h - Venugopal Dhoot redesignated Managing Director; Deepak Sharma appointed CFO; changes effective March 6, 2026; postal ballot for MD.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ff0892d7-6f40-440b-a15b-35ef3512290d.pdf) |
| 2h - Redesignation of Venugopal Dhoot as Managing Director until Sept 25, 2030; Deepak Sharma appointed CFO effective March 6, 2026. | [Board Meeting Outcome for Outcome Of Board Meeting 2h - Redesignation of Venugopal Dhoot as Managing Director until Sept 25, 2030; Deepak Sharma appointed CFO effective March 6, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/89197a5e-f80c-42bb-a031-fdca528b671b.pdf) |
| 29 Apr - Received repeat international body care products order worth $151,200 (₹143 lakh), executable in 45 days. | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 29 Apr - Received repeat international body care products order worth $151,200 (₹143 lakh), executable in 45 days.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/52d0aa11-ca48-4c15-a16d-34374e6c68db.pdf) |
| 29 Apr - Received repeat international body care products order worth $151,200 (₹143 lakh), executable in 45 days. | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 29 Apr - Received repeat international body care products order worth $151,200 (₹143 lakh), executable in 45 days.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/52d0aa11-ca48-4c15-a16d-34374e6c68db.pdf) |
| 28 Mar - Board approved preferential issue of fully convertible warrants aggregating Rs.21 crore; shareholder approval via postal ballot pending. | [Announcement under Regulation 30 (LODR)-Raising of Funds 28 Mar - Board approved preferential issue of fully convertible warrants aggregating Rs.21 crore; shareholder approval via postal ballot pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/00cfb28e-c510-436f-aa68-282fe47f3032.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b36a6b0c-6433-4658-9a68-8f7a0daa4fa0.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f8d3318-b5f2-438e-9911-0d4a3230f61d.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e44c1a94-75df-41fd-92fc-7d615fd87c15.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf41882f-ca96-4734-b1d2-f14820ed4bc6.pdf) |
| 2026-08-31 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83a45e6-0292-4632-be03-37dbc5728187.pdf) |
| 2026-08-31 | [Shareholder Meeting For 34Th Annual General Meeting For The Financial Year 2025-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=788f471d-0a2f-44ed-bd52-9c10f6a85dce.pdf) |
| 2026-08-31 | [Update Regarding Letter Sent To Shareholders](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da589fb2-b7f9-434d-a01a-70d818ad8f92.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd318c40-efdf-44c7-b5fe-2664d2b652dd.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4456b968-3d44-445a-b003-3c9761316905.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22640bf8-d705-4cd2-a168-f257bba14dea.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Results- Financial Results For Quarter Ended June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82dee1ac-c1a4-445a-b73c-2b66bccf030d.pdf) |
| 2026-05-30 | [Results For The 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cea91105-575c-4394-a7f0-3ca739289c9f.pdf) |
| 2026-02-14 | [Unaudited Financial Results Of The Quarter Ended 31.12.2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f490b64f-94a7-465d-8bde-68ba6122cb55.pdf) |
| 2025-11-12 | [Results-Financial Results For September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e6def86-7bf6-4378-8569-445411284f18.pdf) |
| 2025-08-12 | [Results-Financial Results For June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a27755d-bd6a-4b6c-82a1-037414d60e42.pdf) |
| 2025-05-30 | [Results-Financial Results For March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad9fd39c-6e62-45eb-b34e-70e032ded97d.pdf) |
| 2025-02-12 | [Results-Financial Results For December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78144e2c-01f6-408c-873c-6deb997ce8bf.pdf) |
| 2024-11-14 | [Results-Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=799a0e32-b151-4fa1-ab09-8590441a312f.pdf) |
| 2024-08-14 | [Results-Financial Results For June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51a06b99-3eb0-472c-8b61-21cec6103cc5.pdf) |
| 2024-05-30 | [Results-Financial Results For March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4978ddb6-662c-4e91-83fd-d86d57be53b3.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-02-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90a49d03-09f6-4106-b079-acfb3c34426d.pdf) |
| 2026-02-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0becb894-624a-4ae8-ae3d-29ace1624e87.pdf) |
| 2025-08-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e14f1798-bee5-4bed-8a61-9a8a6b912b6c.pdf) |
| 2024-09-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c992a66c-789f-4909-8ad7-c30f0c647db6.pdf) |
| 2024-06-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=148989cb-6cdd-47ef-a81c-bb8ce6053bd2.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2024 | [Concall - Sep 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c992a66c-789f-4909-8ad7-c30f0c647db6.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c57da3f1-7097-4122-9810-09998f393885.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a2a91639-6ee6-478d-bbff-75cdf1004972.pdf) |
| Dec 2021 | [Concall - Dec 2021](https://archives.nseindia.com/corporate/AAATECH_21122021160617_INTIMATION.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e14f1798-bee5-4bed-8a61-9a8a6b912b6c.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/SME_AR_20407_AAATECH_2021_2022_18072022111900_07182022120002.zip) |
| from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/SME_AR_18953_AAATECH_2020_2021_27082021145147_08272021202003.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/15932500-9274-49a6-8556-c3f57bee3b3f.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c6d8a005-9ebc-4234-82c8-8de92c40973e.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a2cc5885-f6e9-4fc0-ab78-515471d9e43c.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/436f7933-e24b-4372-989b-b97f25abda5e.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b463f147-2df5-458a-ad29-63a3dd990be1.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f4e314af-0704-4eff-a578-4f3eaec5ba34.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/511523/74851511523.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/511523/70139511523.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2024-06-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c57da3f1-7097-4122-9810-09998f393885.pdf) |
| 2024-02-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2a91639-6ee6-478d-bbff-75cdf1004972.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2024-06-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec3c8a35-58ae-4569-9712-192195f584c9.pdf) |
| 2024-02-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78e2fb93-43d6-4d85-96c7-85a46f99d319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:05.992Z.